AISMA 2014 - 4th Annual Anti-Inflammatories: Small Molecule Approaches

CHI’s Anti-Inflammatories: Small Molecule Approaches continues to be the ONLY meeting in the inflammation field that focuses on the discovery and development of oral or small-molecule based drug candidates. Anti-body based therapies, while effective and safe, are costly and harder to administer than an oral pill. With the JAK inhibitors progressing in the clinic and perhaps one on the market soon, the promise of a new anti-inflammatory as good as the non-steroidal anti-inflammatories (NSAIDS) but without the gastric side effects, is tangible. Other oral anti- inflammatory drug candidates are on the horizon as well. This year’s meeting will provide an update and highlight the medicinal chemistry optimizations that are allowing kinase inhibitor candidates to advance in clinical trials. Non-kinase targets will be a focus as well.